KORU Medical Systems, Inc. (KRMD)

KORU Medical Systems, Inc. (KRMD) Healthcare & Pipeline Overview

KORU Medical Systems, Inc. is a leader in portable medical devices, focusing on the ambulatory infusion market with innovative solutions such as the FREEDOM infusion systems, catering to both domestic and international healthcare needs.

What Is the Investment Thesis for KRMD?

KORU Medical Systems, Inc. presents a unique investment thesis driven by its strong product portfolio in the ambulatory infusion market, which is projected to grow significantly. The company's gross margin stands at 60.1%, indicating efficient production and pricing strategies. Despite a current profit margin of -5.3%, the focus on expanding its product offerings and enhancing distribution channels could lead to improved profitability. The ambulatory infusion market is expected to grow at a CAGR of 10% over the next five years, driven by increasing demand for home healthcare solutions. KORU's commitment to education and training further strengthens its market position, as it enhances customer loyalty and product utilization. However, potential regulatory challenges and competition in the medical device sector remain key risk factors that could impact growth.

Based on FMP financials and quantitative analysis

KRMD Key Highlights

• Market capitalization of $211.98M indicates a small-cap status with potential for growth.
• Gross margin of 60.1% reflects strong pricing power and cost management.
• Profit margin of -5.3% suggests current operational challenges but room for improvement.
• Beta of 0.54 indicates lower volatility compared to the broader market, appealing to risk-averse investors.
• No dividend yield as the company reinvests earnings into growth initiatives.

Who Are KRMD's Competitors?

KRMD is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are KRMD's Key Strengths?

• Innovative product line tailored for ambulatory infusion.
• High gross margin indicating effective cost management.
• Established brand presence in the medical device industry.
• Strong focus on education and customer support.

What Are KRMD's Weaknesses?

• Current negative profit margin indicating operational challenges.
• Limited market penetration compared to larger competitors.
• Dependence on a narrow product line for revenue generation.
• Relatively small workforce may limit scalability.

What Could Drive KRMD Stock Higher?

• Launch of new product lines aimed at enhancing patient comfort and safety.
• Expansion of distribution channels to increase market reach and sales.
• Continuous investment in research and development to innovate new infusion technologies.

What Are the Key Risks for KRMD?

• Negative return on equity (-13.6%) — the business is not currently generating profit on shareholder capital.
• Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
• Regulatory hurdles that may delay product approvals and market entry.
• Intense competition from established players in the medical device industry.
• Economic downturns that could impact healthcare spending and device adoption.

What Are the Growth Opportunities for KRMD?

• Growth opportunity 1: The ambulatory infusion market is projected to reach $5 billion by 2028, driven by an increasing number of patients requiring at-home infusion therapies. KORU Medical's innovative FREEDOM infusion systems are well-positioned to capitalize on this trend, offering patients greater mobility and comfort, thus enhancing their market share.
• Growth opportunity 2: Expansion into international markets presents a significant growth avenue for KORU Medical Systems. With increasing demand for portable medical devices globally, the company can leverage its existing product lines to penetrate new regions, potentially increasing revenues by 20% over the next three years.
• Growth opportunity 3: The rise of telehealth and remote patient monitoring is creating demand for portable medical devices. KORU Medical's focus on education and training for clinicians and patients positions it to benefit from this trend, with an anticipated market growth of 15% annually in related sectors.
• Growth opportunity 4: Strategic partnerships with healthcare providers and distributors can enhance KORU Medical's market reach and product adoption. Collaborations could lead to increased sales and brand visibility, contributing to a projected revenue growth of 25% over the next five years.
• Growth opportunity 5: Continued investment in research and development to innovate new products can drive future growth. By introducing advanced infusion technologies and expanding its product portfolio, KORU Medical can capture emerging market segments and increase its competitive edge.

What Opportunities Does KRMD Have?

• Growing demand for home healthcare solutions.
• Expansion into international markets to increase sales.
• Rising telehealth trends creating demand for portable devices.
• Strategic partnerships to enhance distribution and visibility.

What Threats Does KRMD Face?

• Intense competition from larger medical device companies.
• Regulatory challenges impacting product approvals.
• Market volatility affecting healthcare spending.
• Potential supply chain disruptions in manufacturing.

What Are KRMD's Competitive Advantages?

• Strong brand recognition in the ambulatory infusion market.
• Innovative product offerings that enhance patient experience.
• Established relationships with healthcare providers and distributors.
• Commitment to education and training, fostering customer loyalty.

What Does KRMD Do?

Founded in 1980 and headquartered in Chester, New York, KORU Medical Systems, Inc. has established itself as a key player in the healthcare sector, particularly in the ambulatory infusion market. The company designs, manufactures, and markets portable medical devices that are crucial for patients requiring infusion therapy. Its flagship products include the FREEDOM infusion systems, which consist of the FREEDOM60 and FreedomEdge syringe drivers, along with HIgH-Flo subcutaneous safety needle sets and precision flow rate tubing. These products are designed to enhance patient comfort and safety during infusion therapy, allowing for greater mobility and independence. KORU Medical also provides comprehensive education and training materials for clinicians, patients, and advocates, ensuring that users are well-informed about the proper use of their devices. The company sells its products through direct sales channels, medical device distributors, and online platforms, enabling it to reach a broad audience. With a workforce of approximately 80 employees, KORU Medical Systems is committed to innovation and quality in its offerings, striving to improve patient outcomes in the healthcare sector.

What Products and Services Does KRMD Offer?

• Design and manufacture portable medical devices for infusion therapy.
• Offer the FREEDOM infusion systems, including syringe drivers and safety needle sets.
• Provide education and training materials for healthcare professionals and patients.
• Sell products through direct sales, distributors, and online platforms.
• Focus on enhancing patient comfort and safety during infusion therapy.

How Does KRMD Make Money?

• Generate revenue through the sale of medical devices and infusion systems.
• Leverage direct sales and distribution partnerships for market penetration.
• Offer educational resources to enhance product usage and customer loyalty.
• Focus on research and development to innovate and expand product offerings.

What Industry Does KRMD Operate In?

The medical instruments and supplies industry is experiencing robust growth, driven by increasing healthcare expenditures and a shift towards home-based care solutions. The ambulatory infusion market is particularly poised for expansion, with a projected CAGR of 10% over the next five years, fueled by advancements in technology and a growing patient population requiring infusion therapies. KORU Medical Systems, Inc. operates in a competitive landscape, facing rivals that also focus on portable medical devices. The company's emphasis on innovation and education differentiates it from competitors, positioning it well to capture market share in this evolving industry.

Who Are KRMD's Key Customers?

• Healthcare providers including hospitals and clinics.
• Patients requiring at-home infusion therapy.
• Medical device distributors and wholesalers.
• Healthcare professionals seeking training and educational resources.

Company Profile

KORU Medical Systems, Inc. operates in the Medical - Instruments & Supplies industry within the Healthcare sector. It is headquartered in Mahwah, US. The company is led by CEO Linda Tharby. KRMD has traded publicly since 1994.

F-Score 3/9Financial Health

KORU Medical Systems, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 10.74 places it in the safe zone, indicating low near-term bankruptcy risk.

ROE -14%Key Financial Metrics

Return on equity for KORU Medical Systems, Inc. stands at -13.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -8.0%, showing how much profit it generates from its asset base. Its free cash flow yield is 0.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.33 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -1.2%, the inverse of the P/E and a quick read on earnings relative to price.

KRMD Valuation & Market Position

With a $211.98M market cap, KORU Medical Systems, Inc. sits in the micro-cap segment of the market. Relative to its peer group, KRMD's quantitative score of 37/100 is below the peer average of 66/100.

FY2026 estForward Outlook

Wall Street analysts project KORU Medical Systems, Inc. revenue of about $48.7M for fiscal 2026, with EPS near $-0.04. The estimate reflects 4 contributing analysts.

KRMD Financials

KRMD Latest News

KRMD Analyst Consensus

KRMD MoonshotScore

KRMD Healthcare Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources